Search Results - "Lehtoranta, K"

Particle emissions characterization from a medium-speed marine diesel engine with two fuels at different sampling conditions by Ntziachristos, L., Saukko, E., Lehtoranta, K., Rönkkö, T., Timonen, H., Simonen, P., Karjalainen, P., Keskinen, J.

“…•Non-volatile marine exhaust rather consists of metallic ash particles than soot.•Heavy species not evaporating at 250°C condense on the non-volatile…”
Get full text

In-depth characterization of exhaust particles performed on-board a modern cruise ship applying a scrubber by Kuittinen, N., Timonen, H., Karjalainen, P., Murtonen, T., Vesala, H., Bloss, M., Honkanen, M., Lehtoranta, K., Aakko-Saksa, P., Rönkkö, T.

“…To comply with environmental regulations, ship operators may adopt exhaust after-treatment devices such as scrubbers or selective catalytic reduction (SCR)…”
Get full text

Methane slip and other emissions from newbuild LNG engine under real-world operation of a state-of-the art cruise ship by Kuittinen, N., Koponen, P., Vesala, H., Lehtoranta, K.

“…Liquefied natural gas (LNG) use as shipping fuel has increased in recent years. While LNG results in lower carbon dioxide (CO2) emissions as well as benefits…”
Get full text

Emissions with Heavy-duty Diesel Engines and Vehicles using FAME, HVO and GTL Fuels with and without DOC+POC Aftertreatment by Murtonen, T., Aakko-Saksa, P., Kuronen, M., Mikkonen, S., Lehtoranta, K.

“…This study presents emission results measured with renewable and synthetic diesel fuels. Three engines and five city buses were studied. The efficiency of…”
Get full text

Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study by Sairanen, Jukka, Tammela, Teuvo L J, Leppilahti, Mikael, Multanen, Markku, Paananen, Ilkka, Lehtoranta, Kari, Ruutu, Mirja

“…In a previous retrospective analysis, cyclosporine A (CyA) was highly efficient in treating patients with interstitial cystitis. A prospective randomized study…”
Get more information

Chemical speciation of PM emissions from heavy-duty vehicles by Cunha-Lopes, I., Lehtoranta, K., Almeida, S.M., Evtyugina, M., Vicente, A., Vicente, E., Kuutti, H., Amato, F., Alves, C.A.

“…Particulate matter (PM) is recognised as the deadliest form of air pollution, with vehicle emissions being one of its most important sources. Verification of…”
Get full text

A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate by Pétas, A, Talja, M, Tammela, T, Taari, K, Lehtoranta, K, Välimaa, T, Törmälä, P

“…A randomized controlled study was done to evaluate the efficacy of the self-reinforced polyglycolic acid spiral stent compared to a suprapubic catheter, and…”
Get more information

Comparison of primary and secondary particle formation from natural gas engine exhaust and of their volatility characteristics by Alanen, Jenni, Simonen, Pauli, Saarikoski, Sanna, Timonen, Hilkka, Kangasniemi, Oskari, Saukko, Erkka, Hillamo, Risto, Lehtoranta, Kati, Murtonen, Timo, Vesala, Hannu, Keskinen, Jorma, Rönkkö, Topi

“…Natural gas usage in the traffic and energy production sectors is a growing trend worldwide; thus, an assessment of its effects on air quality, human health…”
Get full text

Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer by Liukkonen, T J; O, Lipponen, P K, Helle, M, Jauhiainen, K E

“…Immunoreactivity of bcl-2, p53, the epidermal growth factor (EGFr) and Ki-67 (MIB-1) proteins was assessed by immunohistochemistry in 185 patients with…”
Get full text

Cost and effectiveness of different treatment alternatives in urinary stone practice by Lehtoranta, K

“…The cost and effectiveness of seventy-six consecutive percutaneous nephrolithotomy (PNL) procedures performed during the years 1990-1992, a sample of 425 ESWL…”
Get more information

Prevalence of clinically confirmed interstitial cystitis in women: a population based study in Finland by Leppilahti, Mikael, Sairanen, Jukka, Tammela, Teuvo L J, Aaltomaa, Sirpa, Lehtoranta, Kari, Auvinen, Anssi

“…Interstitial cystitis (IC) is a clinical condition occurring predominantly in women that is characterized by irritative voiding symptoms, including urinary…”
Get more information

Residual stones after percutaneous nephrolithotomy; sensitivities of different imaging methods in renal stone detection by Lehtoranta, K, Mankinen, P, Taari, K, Rannikko, S, Lehtonen, T, Salo, J

“…Kidneys of 35 renal stone patients treated with percutaneous nephrolithotomy (PNL) were examined at 12-36 months (mean 23 months) after the procedure by plain…”
Get more information

Treatment of urinary stones by extracorporeal shock wave lithotripsy by Lehtoranta, K, Salo, J, Lindell, O, Lehtonen, T

“…A total of 1641 ESWL-treatments were performed in 948 patients at Helsinki University Central Hospital between June 1989 and December 1991. In a series of 816…”
Get more information

Results of the management of ureteric stones with the ureterorenoscope by Lehtoranta, K, Rannikko, S, Lindell, O, Lehtonen, T

“…Eighty ureterorenoscopies (URS) were performed for stone removal in 67 patients between January 1985 and April 1988. The success rates for stone removal were…”
Get more information

Early experience with percutaneous nephrolithotomy by Lehtoranta, K, Lindell, O, Rannikko, S, Lehtonen, T

“…Fifty-four percutaneous nephrolithotomy (PNL) procedures were performed in 41 patients between May 1986 and December 1987. Six patients required more than one…”
Get more information

CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY by ANDERSEN, JT, EKMAN, P, WOLF, H, BEISLAND, HO, JOHANSSON, JE, KONTTURI, M, LEHTONEN, T, TVETER, K, BODKER, A, VEDEL, O

Get full text

553Cyclosporine a and pentosan polysulfate in the treatment of interstitial cystitis: A randomised prospective study by Sairanen, J., Tammela, T., Leppilahti, M., Paananen, I., Multanen, M., Onalt, M., Lehtoranta, K., Forsell, T., Ruutu, M.

Get full text

517 Invance male sling for the treatment of post-prostatectomy incontinence: Early results and complications by González Martin, M., Alvarez Castelo, L., Giberti, C., Hubner, W., Iiker, Y., Kulaksizoglu, H., Lehtoranta, K., Schramek, P.

Get full text

Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group by Andersen, J T, Ekman, P, Wolf, H, Beisland, H O, Johansson, J E, Kontturi, M, Lehtonen, T, Tveter, K

“…To study if placebo-induced improvement in men with symptomatic benign prostatic hyperplasia (BPH) is maintained over 2 years, and to study the efficacy and…”
Get full text

Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity by Lehtoranta, Kari, Tainio, Hanna, Lukkari-Lax, Eeva, Hakonen, Tiina, Tammela, Teuvo L J

“…To determine the pharmacokinetics of oxybutynin and its main active metabolite, N-desethyloxybutynin, after multiple dosage (5 mg/30 ml three times daily) of…”
Get more information